• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. ALERE HCG CASSETTE (20MIU/ML) 30T; HCG PREGNANCY TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. ALERE HCG CASSETTE (20MIU/ML) 30T; HCG PREGNANCY TEST Back to Search Results
Model Number 92210
Device Problem False Negative Result (1225)
Patient Problem Menstrual Irregularities (1959)
Event Date 02/13/2018
Event Type  Injury  
Manufacturer Narrative
Investigation pending.
 
Event Description
The patient previously received a positive result using a home pregnancy test.On (b)(6) 2018, the patient was tested at the facility to confirm the result of the home pregnancy test.A urine sample was collected and produced a negative result using an alere hcg cassette.The patient was instructed to follow up with her physician or return for a retest.On (b)(6) 2018, the patient arrived at the emergency room presenting with bleeding and pain.An ultrasound was conducted and confirmed the pregnancy.The patient was determined to be five weeks pregnant.The patient was later discharged from the emergency room without further bleeding or pain.The customer stated a first-morning sample is typically not used.Troubleshooting was conducted with the customer.The customer was advised that very diluted urine specimens (as indicated by low specific gravity) may not contain representative levels of hcg.Additionally, false negative results may occur when the levels of hcg are below the sensitivity level of the test.When pregnancy is suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Manufacturer Narrative
Returned product was not received.Retention devices were tested in-house with a qc cut-off hcg standard.All devices showed the correct positive results at the read time and met qc specifications.No false negative results were obtained during in-house testing.Manufacturing batch record review did not uncover any abnormalities.The quantity of urine hcg levels may be low in the early stages of pregnancy.Urine samples are more likely influenced by many factors (such as take in too much water or renal dysfunction) which will dilute the urine sample.Per pi, very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.If pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.Because the specimen associated with the complaint was not returned for investigation, a root cause could not be determined based on the information provided.Based on the information available, there is no indication of a product deficiency and no corrective action is required.(report source) corrected to remove company representative and include consumer.
 
Manufacturer Narrative
Investigation conclusion: returned and retention devices were tested in-house with a qc cut-off hcg standard.All devices showed the correct positive results at the read time and met qc specifications.No false negative results were obtained during in-house testing.The product performed as expected.Manufacturing batch record review did not uncover any abnormalities.The quantity of urine hcg levels may be low in the early stages of pregnancy.Urine samples are more likely influenced by many factors (such as take in too much water or renal dysfunction) which will dilute the urine sample.Per pi, very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.If pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.Because the specimen associated with the complaint was not returned for investigation, a root cause could not be determined based on the information provided.Based on the information available, there is no indication of a product deficiency and no corrective action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE HCG CASSETTE (20MIU/ML) 30T
Type of Device
HCG PREGNANCY TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
MDR Report Key7378741
MDR Text Key103729153
Report Number2027969-2018-00033
Device Sequence Number1
Product Code JHI
UDI-Device Identifier10815845020130
UDI-Public(01)10815845020130(17)190930(10)HCG7090141
Combination Product (y/n)N
PMA/PMN Number
K062361
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup,Followup
Report Date 03/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Model Number92210
Device Lot NumberHCG7090141
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/08/2018
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/01/2018
Initial Date FDA Received03/28/2018
Supplement Dates Manufacturer Received04/27/2018
05/14/2018
Supplement Dates FDA Received05/02/2018
05/29/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age26 YR
-
-